- ACS in elderly man vasculopath with Skeleton and skin
- Stent thrombosis or Restenosis: the dilemma of an equivocal STEMI patient
- Transaxillary transcatheter aortic valve implantation (TAVI) as valve-in-valve procedure due to degeneration of an aortic bioprosthesis
- A chronic total occlusion (CTO) of ostial LAD in a young patient
- Percutaneous LAA closure in an elderly woman with contra-indication to oral anticoagulant therapy
- Antithrombotic strategy during PCI: challenging situations
- Multivessel disease and cardiac arrest
- A Large Atrial Septal Defect in a 59 year old male patient
Nurses and Technicians
tamim kanaan – December 20, 2014
“Denying CABG by the patient , PCI to LM-LAD and trying to open the RCA with the good retrograde f...”
Iyad Albaghdadi – December 20, 2014
“As there is retrograde for RCA, it's reasonable to attempt open it first, and later PCI for LM an...”
muhammad irfan – December 20, 2014
“He has unprotected LMS which has distal disease and critical proximal disease in LAD. RCA and LCx...”
Attila Thury – December 16, 2014
“"Thank your for the question. Theoretically, future repeat intervention will be "easy" once the p...”
aksüyek çelebi – December 14, 2014
“transradial aprroach should be used in correct patients without a fashion like manner. every inte...”
European Interventional Cardiology Fellows Course
EAPCI organised its first European Fellows Course at the European Heart House on 11-12 July 2014. 85 participants from 30 countries were updated on standards of percutaneous coronary intervention (PCI), including material selection, indications for PCI, treatment of specific lesion subsets and interventional pharmacology.
Access the slides from previous courses:
6th European Interventional Cardiology Fellow Course, Krakow 2013
5th European Interventional Cardiology Fellow Course, Krakow 2012
4th European Interventional Cardiology Fellow Course, Krakow 2011
Why a Fellows Course in Europe?
Interventional Cardiology was born in Europe and Europe has led the development and the scientific validation of many of the new devices and techniques, which have made angioplasty the most frequently applied method of myocardial revascularisation. Despite the worldwide recognition of the high quality of many European centres, and with the notable exception of France, which has actively engaged in interventional training programs for at least 10 years, Europe has remained behind in terms of approved interventional cardiology training programs.
The European Association of Percutaneous Cardiovascular Intervention is actively trying to fill this gap and has developed a Curriculum and Syllabus of Interventional Cardiology published in EuroIntervention in 2006 with the intention to support the development of a homogeneous high quality in interventional cardiology in all European countries.
Aim of the Course
This course is designed to aid the continued development of medical doctors who have started or have recently completed a program of training in Interventional Cardiology.
Who should attend?
Cardiology Fellows who have been accepted for training in Interventional Cardiology, are performing their period of training, or young cardiologists who have recently completed their training or wish to refresh their interventional training. To allow full interaction, a maximum number of 130 attendants will be allowed with mandatory confirmation of their training supervisor that they will be, are or have been engaged in a program of interventional training for at least 1 year.
What should I expect from this course?
All lectures will be given by recognized experts drawn from the international faculty. They will cover in depth all the aspects of the subject discussed, from the basics to the latest developments.
Lectures will be open to questions from the participants. Review of cases and complications, in a preliminary session or integrated in the lectures or questions, will offer examples of practical applications of the concepts discussed. The breaks will allow interaction with the Faculty and colleagues.
This one-to-one interaction will hopefully establish links and long-term relationships helpful for personal development and a greatest integration of European professionals in Interventional Cardiology.